MedPath

Phase I/II study of carboplatin and nab-paclitaxel and concurrent thoracic radiation for patients with Locally advanced NSCLC

Phase 1
Recruiting
Conditions
ocally advanced non-small cell lung cancer
Registration Number
JPRN-UMIN000020359
Lead Sponsor
Gunma University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) Interstitial pneumonia or pulmonary fibrosis 2) Pleural effusion, cardiac effusion or ascites requring drainage 3) Active double cancers 4) Uncotrollable angiona pectorias, cardian infarction, haear failure, diabetes mellitus, hypertension and severe infection 5) symptomatic brain metastasis 6) pregnancy 7) Alleary against CBDCA or nab-PTX 8) Inappropriate patients in this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath